October 8, 2004
For Immediate Release

HRL LABORATORIES ANNOUNCES MAJOR RESTSRUCTURING OF BOARD OF DIRECTORS

LOS ANGELES, October 8, 2004-- HRL Laboratories, LLC, a research and development limited liability company owned by Boeing, General Motors and Raytheon, announced today a major restructuring of its Board of Directors, reflecting a new corporate governance model. HRL is adding external Directors, including an external Chairman of the Board, and expanding the Board from seven to ten members.  

Dr. Paul Kaminski, Dr. George Heilmeier and Professor George Whitesides will serve as the initial three external Board members and Dr. Kaminski will serve as the Chairman of the Board. The Board will continue to include HRL's President and CEO Dr. Matthew Ganz and two members designated by each of HRL's LLC Members, Boeing, General Motors and Raytheon.

Dr. Kaminski is Chairman and CEO of Technovation, Inc. From 1994 to 1997 he served as the Undersecretary of Defense for Acquisition and Technology. Previously he was Chairman and CEO of Technology Strategies and Alliances, an investment banking and consulting firm. He has also served as Chairman of the Defense Science Board and as a member of the Defense Policy Board. He has also served as a director or trustee for several technology oriented companies. He previously served for twenty years as an Air Force Officer.

Dr. Heilmeier is Chairman Emeritus of Telcordia Technologies, formerly Bellcore. Previously he served as Senior Vice President and Chief Technology Officer for Texas Instruments. He also served in government from 1970 to 1977 as Assistant Director of Defense Research & Engineering in charge of all Department of Defense programs in electronics, computer technology, and the physical sciences. He became Director of DARPA in 1974 and initiated major efforts in stealth aircraft, space-based lasers, and reconnaissance systems, infrared technology, and artificial intelligence. Dr. Heilmeier has served as a board member or advisor to several private and publicly traded companies. He has also served on numerous government advisory boards including the Defense Science Board.

Professor Whitesides is Mallinckrodt Professor of Chemistry at Harvard University. Previously he was a member of the faculty of the Massachusetts Institute of Technology. Professor Whitesides and his group work in four areas: biochemistry, materials science, catalysis and physical organic chemistry. He has been a recipient of numerous awards and he serves on several advisory boards. He is a member of the American Academy of Arts and Sciences and the National Academy of Sciences. He has also served as an advisor to or board member for several companies and on several government advisory boards, including the Defense Science Board.

Upon the announcement of these changes, Dr. Matthew W. Ganz, HRL's President and CEO, said, "We are extremely pleased to announce these changes and we are especially pleased to have identified three extremely capable individuals to serve as our initial external board members. The three new board members bring a unique combination of outstanding credentials, boardroom experience, and experience in technology management. In addition, their outside perspectives will help make HRL better able to rapidly identify opportunities for the creation of innovative new technologies."

HRL's new Board Chairman, Dr. Kaminski, added," All three of the new external Board Members are very pleased to be joining the HRL team. We each believe that HRL represents a unique opportunity as a research and development lab for three major corporations. Through the identification and development of potentially game-changing technologies, HRL is uniquely positioned to create synergistic opportunities for its owners."

The new Board's first meeting was held on Sept. 29 and 30, 2004 in Malibu.

HRL Laboratories, LLC is a corporate R&D laboratory owned by Boeing, General Motors, and Raytheon. HRL performs R&D services for its three owners, for the U.S. government, and for other commercial entities.

###